Digital Access

Digital Access
Access daily-chronicle.com from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, prep sports, Chicago sports, local and regional entertainment, business, home and lifestyle, food, classified and more!

Text Alerts

Text Alerts
Choose your news! Select the text alerts you want to receive: breaking news, prep sports scores, school closings, weather, and more.

Email Newsletters

Email Newsletters
We'll deliver news & updates to your inbox. Sign up for free e-newsletters today.
State

IDOC says inmate hepatitis drug not as costly

SPRINGFIELD — Illinois prison officials say a new hepatitis drug likely won't be as costly as initially reported.

Authorities worried Sovaldi could cost the Illinois Department of Corrections tens of millions of dollars if it was used to treat inmates who have the blood-borne infection.

But the Springfield bureau of Lee Enterprises reports (http://bit.ly/1kWzba7 ) the drug would cost less than $6 million if it's used.

Studies have shown the medication has a cure rate of 95 percent.

Illinois lawmakers introduced legislation banning the agency from using the drug that can cost as much as $61,000 for a single dose, but the measure hasn't been taken up.

IDOC spokesman Tom Shaer says the previous cost estimates are "wildly inaccurate" and said the legislation isn't necessary.

Loading more